文献类型：期刊文献

英文题名：Design and application of hydrophilic bimetallic metal-organic framework magnetic nanoparticles for rapid capture of exosomes

作者：Zhang, Chenhui[1];Pan, Yini[1];Zhao, Yameng[1];Wang, Peiyao[1];Zhang, Lingyi[1];Zhang, Weibing[1]

机构：[1]East China Univ Sci & Technol, Sch Chem & Mol Engn, Shanghai Key Lab Funct Mat Chem, Shanghai, Peoples R China

年份：2021

卷号：1186

外文期刊名：ANALYTICA CHIMICA ACTA

收录：;EI(收录号：20214010974774);WOS:【SCI-EXPANDED(收录号:WOS:000713666000005)】；

基金：We gratefully acknowledged the support of the National Natural Science Foundation of China (No.21974045) , the Science and Technology Commission of Shanghai Municipality (No.19142201100, 6142200500) , the Fundamental Research Funds for the Central Universities (JKJ01211718) .

语种：英文

外文关键词：Bimetallic metal-organic framework; Hydrophilicity; Exosome; Cell; Urine

摘要：Functional materials with good biocompatibility have been widely used in the study of genomics, proteomics and disease diagnosis, which has improved the progress of life science. In this paper, the material not only exhibited a strong affinity to the phosphate groups on the exosomal membrane due to the coexistence of Zr-O clusters and Ti4+, but also owned great hydrophilicity to reduce non-specific adsorption of contaminated proteins, achieving the separation and purification of exosomes from complex biosamples. The model exosomes extracted by ultracentrifugation (UC) were used to evaluate the feasibility of Fe3O4@UiO-66-NH2@PA-Ti4+ capturing exosomes. The process of Fe3O4@UiO-66-NH2@PA-Ti4+ capturing exosomes was simple to operate with a high recovery rate (97.3%) within a short time (5 min). Then Fe3O4@UiO-66-NH2@PA-Ti4+ was further applied to capture exosomes in media and urine followed by the downstream proteomics analysis. 348 and 284 exosomal proteins were identified for cell medium and urine, respectively. This work shows great potential of the material for subsequent function research of disease-related exosomes by separating exosomes rapidly and efficiently. (C) 2021 Elsevier B.V. All rights reserved.